Juvensis Therapeutics
Latest round
- Angel
Last raised
- Aug 2022
Total raised
- Undisclosed
Investors
- 2
About Juvensis Therapeutics
Based in Shanghai, China, and founded in 2021, Juvensis Therapeutics operates as a gene therapy product developer. The company has built a new generation telomere precision modulation technology platform to focus on unmet clinical needs such as heart failure. It has developed the telomere protection protein that can block the vicious cycle of telomere damage and mitochondrial dysfunction, thus promoting the recovery of myocardial function. The company generates revenue by providing gene therapy products and in vitro cellular products business. The company will use the funds to advance the clinical development of its core cardiac gene therapy pipeline, JV101, and expand research into heart failure indications.
Who invested in Juvensis Therapeutics
2 investors across 1 round
See all investors in Juvensis Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Aug 23, 2022
Amount
Undisclosed
Investors
Questions about Juvensis Therapeutics
Who invested in Juvensis Therapeutics?
Juvensis Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Juvensis Therapeutics raised?
Juvensis Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Juvensis Therapeutics last raise money?
Juvensis Therapeutics's most recent round on record is a Angel, in Aug 2022.
What does Juvensis Therapeutics do?
Based in Shanghai, China, and founded in 2021, Juvensis Therapeutics operates as a gene therapy product developer.
Where is Juvensis Therapeutics headquartered?
Juvensis Therapeutics is headquartered in Shanghai, China.
Which VCs invest in companies like Juvensis Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Juvensis Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Juvensis Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.